Drug resistance among top threats: WHO
NEW DELHI: Antimicrobial Resistance (AMR) has been identified as one of the 10 threats to global health in 2019 by World Health Organisation (WHO). The other threats on this list include HIV, Ebola, dengue,
Ebola Virus Disease ( Ebola Hemorrhagic Fever)
-
Africa to Set Up Disease Control Centre
Malabo — Africa is expected to establish a continental Centre for Disease Control as part of its fight against communicable diseases that have retarded countries' growth. President Mugabe, who is the
-
Africa: Two New Trials of Ebola Vaccines Begin in Europe, Africa
Two new Ebola vaccine trials began on Wednesday with volunteers in Britain, France and Senegal getting "prime-boost" immunisations developed by Bavarian Nordic, GlaxoSmithKline and Johnson & Johnson.
-
Liberia confirms new Ebola case as outbreak spreads
A Liberian woman has died of Ebola in a hospital in Monrovia shortly after being admitted, becoming the sixth confirmed case and second death since the virus resurfaced last month, a senior medical official
-
Liberia Confirms Sixth Ebola Case As Outbreak Spreads
A Liberian woman has died of Ebola Virus Disease in a hospital in Monrovia shortly after being admitted hospital authorities said on Tuesday. She becomes the sixth confirmed case of the virus since
-
Nigeria: Inhalable Ebola Vaccine Discovered
Researchers at the University of Texas Medical Branch (UTMB), Galveston have discovered an inhalable vaccine that can protect rhesus macaque monkeys against severe illness and death when they were exposed
-
South Africa: WHO Proposes Roadmap to Deal With Future Health Outbreaks
The World Health Organisation (WHO) has called for a Central National Emergency Operations Centre to be established and to be on stand-by to deal with future disease outbreaks and related emergencies.
-
Researchers develop aerosolized vaccine that protects primates against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola. The findings
-
Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responses
<p>Direct delivery of aerosolized vaccines to the respiratory mucosa elicits both systemic and mucosal responses. This vaccine strategy has not been tested for Ebola virus (EBOV) or other hemorrhagic fever
-
How much donor financing for health is channelled to global versus country-specific aid functions?
The slow global response to the Ebola crisis in west Africa suggests that important gaps exist in donor financing for key global functions, such as support for health research and development for diseases
-
Ebola-stricken nations need $700 million to rebuild healthcare
Guinea, Liberia and Sierra Leone need a further $696 million (£446.13 million) in donor funding to rebuild their battered health services over the next two years in the wake of the deadly Ebola epidemic,